Pseudolaric Acid B Targets CD147 to Selectively Kill Acute Myeloid Leukemia Cells

Author:

Zou Sheng1ORCID,Parfenova Ekaterina1ORCID,Vrdoljak Nikolina1,Minden Mark D.2,Spagnuolo Paul A.1

Affiliation:

1. Department of Food Science, University of Guelph, Guelph, ON N1G 2W1, Canada

2. Princess Margaret Cancer Center, Ontario Cancer Institute, Toronto, ON M5G 2M9, Canada

Abstract

Acute myeloid leukemia (AML) is an aggressive blood cancer. With low survival rates, new drug targets are needed to improve treatment regimens and patient outcomes. Pseudolaric acid B (PAB) is a plant-derived bioactive compound predicted to interact with cluster of differentiation 147 (CD147/BSG). CD147 is a transmembrane glycoprotein overexpressed in various malignancies with suggested roles in regulating cancer cell survival, proliferation, invasion, and apoptosis. However, the detailed function of PAB in AML remains unknown. In this study, AML cell lines and patient-derived cells were used to show that PAB selectively targeted AML (IC50: 1.59 ± 0.47 µM). Moreover, proliferation assays, flow cytometry, and immunoblotting confirmed that PAB targeting of CD147 resulted in AML cell apoptosis. Indeed, the genetic silencing of CD147 significantly suppressed AML cell growth and attenuated PAB activity. Overall, PAB imparts anti-AML activity through transmembrane glycoprotein CD147.

Funder

University of Guelph and the Leukemia and Lymphoma Society of Canada

Publisher

MDPI AG

Reference60 articles.

1. Chennamadhavuni, A., Lyengar, V., Mukkamalla, S.K.R., and Shimanovsky, A. (2023). Leukemia. StatPearls [Internet], StatPearls Publishing.

2. Sabath, D.E. (2013). Leukemia. Brenner’s Encyclopedia of Genetics, Academic Press. [2nd ed.].

3. (2024, April 16). Statistics Canada Table 13-10-0158-01 Age-Specific Five-Year Net Survival Estimates for Primary Sites of Cancer, by Sex, Three Years Combined. Available online: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310015801&pickMembers%5B0%5D=1.1&pickMembers%5B1%5D=3.1&pickMembers%5B2%5D=4.51&cubeTimeFrame.startYear=2006+%2F+2008&cubeTimeFrame.endYear=2010+%2F+2012&referencePeriods=20060101%2C20100101.

4. AML: Treatment-Related Toxicity or Not?;Avvisati;Blood,2007

5. The Impact of Therapy-Related Acute Myeloid Leukemia (AML) on Outcome in 2853 Adult Patients with Newly Diagnosed AML;Kayser;Blood,2011

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3